Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

COEP Coeptis Therapeutics Holdings Inc

-0.0298 (-6.93%)
Apr 12 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 234,949
Bid Price 0.4001
Ask Price 0.415
News -
Day High 0.439


52 Week Range


Day Low 0.40
Company Name Stock Ticker Symbol Market Type
Coeptis Therapeutics Holdings Inc COEP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0298 -6.93% 0.4002 19:59:38
Open Price Low Price High Price Close Price Prev Close
0.43 0.40 0.439 0.4186 0.43
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
447 234,949 $ 0.4129035 $ 97,011 - 0.2851 - 2.1899
Last Trade Time Type Quantity Stock Price Currency
18:40:30 2 $ 0.4002 USD

Coeptis Therapeutics Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
407.59M 34.11M - 0 -37.57M -1.10 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Coeptis Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No COEP Message Board. Create One! See More Posts on COEP Message Board See More Message Board Posts

Historical COEP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.3350.480.30990.4025614539,3630.065219.46%
1 Month0.35030.480.28510.3557554307,4600.049914.24%
3 Months0.55080.6790.28510.4553689263,424-0.1506-27.34%
6 Months1.201.380.28510.6434114191,591-0.7998-66.65%
1 Year1.362.18990.28511.04171,143-0.9598-70.57%
3 Years8.208.75510.28511.31185,914-7.80-95.12%
5 Years8.208.75510.28511.31185,914-7.80-95.12%

Coeptis Therapeutics Description

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. is headquartered in Wexford, Pennsylvania.

Your Recent History

Delayed Upgrade Clock